Showing 1811-1820 of 3257 results for "".
Prednisone-induced DRESS Syndrome
https://practicaldermatology.com/topics/general-topics/prednisone-induced-dress-syndrome/21572/This unusual reaction was resolved with a switch to a Group C steroid.The Importance of Mentorship
https://practicaldermatology.com/youngmd-connect/wrap-ups/the-importance-of-mentorship/26950/The Importance of MentorshipLyme Disease Update
https://practicaldermatology.com/topics/general-topics/lyme-disease-update/20604/Exploring current thinking about Lyme Disease diagnosis and treatment.Lasers In Practice: Reducing the Appearance of Stretch Marks with Multiple Laser Technologies
https://practicaldermatology.com/topics/general-topics/lasers-in-practice-reducing-the-appearance-of-stretch-marks-with-multiple-laser-technologies/21769/Traditionally difficult to treat, stretch marks may respond to a combination of modalities provided in sync.Keep Your Dermatology Practice HIPAA Compliant With These 5 Photo Tips
https://practicaldermatology.com/topics/practice-management/keep-your-dermatology-practice-hipaa-compliant-with-these-5-photo-tips/20684/Recommendations for managing patient photos while preserving privacy.Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsA Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Dermatology and the ICD-10 Code Conundrum
https://practicaldermatology.com/topics/practice-management/dermatology-and-the-icd-10-code-conundrum/21372/EHRs equipped for ICD-10 can make the impending transition smooth for any practice.